---
title: Validate wearable assessment of walking
nct_id: NCT05874739
status: RECRUITING
sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT05874739"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05874739"
last_fetched: "2026-05-10T14:07:32.916Z"
source: "Parkinson's Pathways (curated)"
---
# Validate wearable assessment of walking

**Goal (in five words):** Validate wearable assessment of walking

**Official Title:** Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study.

**Trial ID:** [NCT05874739](https://clinicaltrials.gov/study/NCT05874739)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Target Enrollment:** 651 participants
- **Start Date:** 2023-05-17
- **Completion Date:** 2025-07-28
- **Conditions:** Parkinson Disease, Aging

## Summary For Families

Mobilise-D's extension aims to validate a digital mobility assessment, to see if wearable sensors can reliably capture everyday walking and balance changes in people with Parkinson's and in older adults. Participants wear a small sensor that records steps, gait speed, stride length, turning and activity patterns in real life, so researchers can compare those objective measures with clinical ratings and track mobility over time. The study is looking for two groups: older control volunteers aged 50 and over who can walk 4 meters unaided and are willing to wear a sensor for about 12 months, and people with Parkinson's already enrolled in the Mobilise-D clinical validation cohort, aged 18 and over with Hoehn and Yahr stages I to III. People with recent major cardiac events, active cancer, dementia, or other neurological or orthopedic conditions that significantly affect walking are excluded.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL

### Full Criteria

```
Control Cohort:

Inclusion Criteria:

* Aged 50 years or over
* Able to walk 4 meters independently without walking aids
* Anticipated availability for 12 months.
* Ability to consent and comply with any study specific procedures.
* Willingness to wear a wearable sensor for mobility monitoring
* Able to read and write in first language in the respective country

Exclusion Criteria:

* Occurrence of any of the following within 3 months prior to informed consent: myocardial infarction, hospitalization for unstable angina, stroke, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), implantation of a cardiac resynchronization therapy device (CRTD), active treatment for cancer or other malignant disease, uncontrolled congestive heart disease (NYHA class \>3), acute psychosis or major psychiatric disorders or continued substance abuse, other neurological or orthopaedic impairment that significantly impacts on gait
* Patients with a clinical diagnosis of PD, COPD, proximal hip fracture or MS
* History of dementia/significant cognitive impairment, or movement disorder (including essential tremor)

PD Cohort

Inclusion Criteria:

* Participant in the Mobilise-D Clinical Validation Study (CVS) PD Cohort - see below.

CVS PD Cohort:

Inclusion criteria:

* Aged 18 or over
* Patients with the clinical diagnosis of PD according to the recent criteria of the Movement Disorder Society
* Hoehn \& Yahr stage I-III

Exclusion Criteria:

* History consistent with Dementia with Lewy Bodies (DLB), atypical parkinsonian syndromes (including multiple system atrophy or progressive supranuclear palsy, diagnosed according to accepted criteria)
* Repeated strokes or stepwise progression of symptoms, leading to a diagnosis of 'vascular parkinsonism'
* Drug-induced Parkinsonism
```

## Locations (1)

- The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom _(54.9733, -1.6140)_
  - Philip Brown — (CONTACT)
  - Alison Yarnall, PhD — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Isabel K Neatrour, MSc — (CONTACT) — +44 (0) 191 2081406 — isabel.neatrour@newcastle.ac.uk
- Alison Yarnall, PhD — (CONTACT) — +44 (0)191 2081279 — alison.yarnall@newcastle.ac.uk

---

*Canonical: https://parkinsonspathways.com/trial/NCT05874739*  
*HTML version: https://parkinsonspathways.com/trial/NCT05874739*  
*Source data: https://clinicaltrials.gov/study/NCT05874739*